These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32397513)

  • 1. Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics.
    Glassman PM; Villa CH; Ukidve A; Zhao Z; Smith P; Mitragotri S; Russell AJ; Brenner JS; Muzykantov VR
    Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32397513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery by red blood cells: vascular carriers designed by mother nature.
    Muzykantov VR
    Expert Opin Drug Deliv; 2010 Apr; 7(4):403-27. PubMed ID: 20192900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.
    Villa CH; Anselmo AC; Mitragotri S; Muzykantov V
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):88-103. PubMed ID: 26941164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.
    Villa CH; Cines DB; Siegel DL; Muzykantov V
    Transfus Med Rev; 2017 Jan; 31(1):26-35. PubMed ID: 27707522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics.
    Wang S; Wang Y; Jin K; Zhang B; Peng S; Nayak AK; Pang Z
    Expert Opin Drug Deliv; 2022 Aug; 19(8):965-984. PubMed ID: 35917435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles.
    Nguyen PHD; Jayasinghe MK; Le AH; Peng B; Le MTN
    ACS Nano; 2023 Mar; 17(6):5187-5210. PubMed ID: 36896898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery by erythrocytes: "Primum non nocere".
    Villa CH; Seghatchian J; Muzykantov V
    Transfus Apher Sci; 2016 Dec; 55(3):275-280. PubMed ID: 27856317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances.
    Zhang E; Phan P; Algarni HA; Zhao Z
    Pharm Res; 2022 Nov; 39(11):2673-2698. PubMed ID: 35794397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells.
    Pan DC; Myerson JW; Brenner JS; Patel PN; Anselmo AC; Mitragotri S; Muzykantov V
    Sci Rep; 2018 Jan; 8(1):1615. PubMed ID: 29371620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte-based drug delivery in Transfusion Medicine: Wandering questions seeking answers.
    Tzounakas VL; Karadimas DG; Papassideri IS; Seghatchian J; Antonelou MH
    Transfus Apher Sci; 2017 Aug; 56(4):626-634. PubMed ID: 28774826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel engineering: Biomimicking erythrocyte as a revolutionary platform for drugs and vaccines delivery.
    Izzati Mat Rani NN; Alzubaidi ZM; Azhari H; Mustapa F; Iqbal Mohd Amin MC
    Eur J Pharmacol; 2021 Jun; 900():174009. PubMed ID: 33722591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modularity of RBC hitchhiking with polymeric nanoparticles: testing the limits of non-covalent adsorption.
    Lenders V; Escudero R; Koutsoumpou X; Armengol Álvarez L; Rozenski J; Soenen SJ; Zhao Z; Mitragotri S; Baatsen P; Allegaert K; Toelen J; Manshian BB
    J Nanobiotechnology; 2022 Jul; 20(1):333. PubMed ID: 35842697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells.
    Pan D; Vargas-Morales O; Zern B; Anselmo AC; Gupta V; Zakrewsky M; Mitragotri S; Muzykantov V
    PLoS One; 2016; 11(3):e0152074. PubMed ID: 27003833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red Blood Cell Membrane Processing for Biomedical Applications.
    Rossi L; Fraternale A; Bianchi M; Magnani M
    Front Physiol; 2019; 10():1070. PubMed ID: 31481901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin.
    Muzykantov VR; Murciano JC; Taylor RP; Atochina EN; Herraez A
    Anal Biochem; 1996 Oct; 241(1):109-19. PubMed ID: 8921172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red Blood Cells as Smart Delivery Systems.
    Han X; Wang C; Liu Z
    Bioconjug Chem; 2018 Apr; 29(4):852-860. PubMed ID: 29298380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies.
    Bhateria M; Rachumallu R; Singh R; Bhatta RS
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1219-36. PubMed ID: 24912015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An erythrocyte membrane-camouflaged biomimetic nanoplatform for enhanced chemo-photothermal therapy of breast cancer.
    Li JQ; Zhao RX; Yang FM; Qi XT; Ye PK; Xie M
    J Mater Chem B; 2022 Mar; 10(12):2047-2056. PubMed ID: 35254366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice.
    Gao C; Wang Y; Sun J; Han Y; Gong W; Li Y; Feng Y; Wang H; Yang M; Li Z; Yang Y; Gao C
    Acta Biomater; 2020 May; 108():285-299. PubMed ID: 32251785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.